Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Weighted Average) (2019 - 2025)

Volitionrx (VNRX) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $87.9 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Shares Outstanding (Weighted Average) rose 28.31% year-over-year to $87.9 million, compared with a TTM value of $82.7 million through Jun 2024, up 29.96%, and an annual FY2023 reading of $71.2 million, up 28.7% over the prior year.
  • Shares Outstanding (Weighted Average) was $87.9 million for Q3 2024 at Volitionrx, up from $82.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $87.9 million in Q3 2024 and bottomed at $41.2 million in Q1 2020.
  • Average Shares Outstanding (Weighted Average) over 5 years is $59.4 million, with a median of $54.2 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 2.7% in 2022, then skyrocketed 36.19% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $44.1 million in 2020, then rose by 19.27% to $52.7 million in 2021, then rose by 5.12% to $55.4 million in 2022, then rose by 28.7% to $71.2 million in 2023, then grew by 23.38% to $87.9 million in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for VNRX at $87.9 million in Q3 2024, $82.7 million in Q2 2024, and $82.0 million in Q1 2024.